Cassava Sciences Inc Financial Statements (SAVA)
|
|
|
|
Report date
|
|
|
01.03.2022 |
28.02.2023 |
28.02.2024 |
03.03.2025 |
12.03.2026 |
|
07.05.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Operating Income, bln rub |
|
|
-32.9 |
-80.0 |
-106.0 |
-141.4 |
-95.4 |
|
-70.8 |
|
EBITDA, bln rub |
? |
|
-32.3 |
-78.7 |
-104.4 |
-141.1 |
-94.5 |
|
-73.1 |
|
Net profit, bln rub |
? |
|
-32.4 |
-76.2 |
-97.2 |
-24.3 |
-91.0 |
|
-77.9 |
|
|
OCF, bln rub |
? |
|
-30.2 |
-77.5 |
-82.0 |
-116.9 |
-32.3 |
|
-29.8 |
|
CAPEX, bln rub |
? |
|
22.2 |
2.71 |
0.414 |
0.103 |
0.581 |
|
0.581 |
|
FCF, bln rub |
? |
|
-52.4 |
-80.2 |
-82.4 |
-117.0 |
-32.8 |
|
-30.4 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
32.9 |
12.0 |
16.5 |
141.4 |
94.5 |
|
95.6 |
|
Cost of production, bln rub |
|
|
0.000 |
68.0 |
89.4 |
0.000 |
0.936 |
|
24.3 |
|
R&D, bln rub |
|
|
24.8 |
68.9 |
89.4 |
69.6 |
26.6 |
|
17.5 |
|
Interest expenses, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Assets, bln rub |
|
|
266.8 |
234.8 |
151.7 |
157.5 |
118.4 |
|
108.4 |
|
Net Assets, bln rub |
? |
|
253.9 |
227.5 |
137.5 |
145.7 |
74.4 |
|
68.1 |
|
Debt, bln rub |
|
|
0.236 |
0.139 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Cash, bln rub |
|
|
233.4 |
201.0 |
121.1 |
128.6 |
95.5 |
|
86.6 |
|
Net debt, bln rub |
|
|
-233.2 |
-200.9 |
-121.1 |
-128.6 |
-95.5 |
|
-86.6 |
|
|
Ordinary share price, rub |
|
|
6.24 |
29.5 |
22.5 |
2.36 |
1.98 |
|
1.96 |
|
Number of ordinary shares, mln |
|
|
39.4 |
40.2 |
41.9 |
46.3 |
48.3 |
|
48.3 |
|
|
Market cap, bln rub |
|
|
246 |
1 188 |
944 |
109 |
96 |
|
94 |
|
EV, bln rub |
? |
|
13 |
987 |
823 |
-19 |
0 |
|
8 |
|
Book value, bln rub |
|
|
253 |
227 |
137 |
146 |
74 |
|
68 |
|
|
EPS, rub |
? |
|
-0.82 |
-1.90 |
-2.32 |
-0.53 |
-1.88 |
|
-1.61 |
|
FCF/share, rub |
|
|
-1.33 |
-2.00 |
-1.97 |
-2.53 |
-0.68 |
|
-0.63 |
|
BV/share, rub |
|
|
6.42 |
5.64 |
3.27 |
3.14 |
1.54 |
|
1.41 |
|
|
FCF yield, % |
? |
|
-21.3% |
-6.76% |
-8.73% |
-107.0% |
-34.3% |
|
-32.2% |
|
ROE, % |
? |
|
-12.8% |
-33.5% |
-70.7% |
-16.7% |
-122.3% |
|
-114.3% |
|
ROA, % |
? |
|
-12.1% |
-32.5% |
-64.1% |
-15.5% |
-76.9% |
|
-71.9% |
|
|
P/E |
? |
|
-7.59 |
-15.6 |
-9.71 |
-4.49 |
-1.05 |
|
-1.21 |
|
P/FCF |
|
|
-4.69 |
-14.8 |
-11.4 |
-0.93 |
-2.91 |
|
-3.11 |
|
P/BV |
? |
|
0.97 |
5.23 |
6.88 |
0.75 |
1.29 |
|
1.39 |
|
EV/EBITDA |
? |
|
-0.39 |
-12.5 |
-7.88 |
0.14 |
0.00 |
|
-0.11 |
|
Debt/EBITDA |
|
|
7.21 |
2.55 |
1.16 |
0.91 |
1.01 |
|
1.18 |
|
|
R&D/CAPEX, % |
|
|
111.7% |
2 542% |
21 600% |
67 609% |
4 577% |
|
3 007% |
|
| Cassava Sciences Inc shareholders |
